Patents by Inventor Eumorphia Remboutsika

Eumorphia Remboutsika has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9777037
    Abstract: The present invention relates to novel neurosteroid derivatives with anti-apoptotic, neuroprotective and neurogenic properties that act on the nervous system as well as methods for making the same and their applications in the treatment and/or prevention or amelioration of neurodegenerative diseases related to neuronal apoptosis or neuronal injury, or conditions related to or resulting from apoptosis, including but not limited to Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis and amyotrophic lateral sclerosis (ALS), retinal degeneration and detachment, peripheral neuropathy caused by genetic abnormalities, diabetes, polio, herpes, AIDS and chemotherapy, brain trauma, or ischemia and stroke. The active compounds are represented by Formula (I): wherein R1, R2, R3, R4, R5, R6, R7, A, B, X, Y and Z are defined in the description of the invention. The present invention also includes compositions which comprise one or more of the compounds of Formula (I).
    Type: Grant
    Filed: June 17, 2008
    Date of Patent: October 3, 2017
    Assignee: BIONATURE E. A. LTD.
    Inventors: Achilleas Gravanis, Theodora Calogeropoulou, Elias Castanas, Andreas Margioris, Ioannis Charalambopoulos, Nikolaos Avlonitis, Vassilios Minas, Vasileia-Ismini Alexaki, Christos Tsatsanis, Michael N. Alexis, Eumorphia Remboutsika, Varvara Vergou, Constantinos Neophytou
  • Publication number: 20100234335
    Abstract: The present invention relates to novel neurosteroid derivatives with anti-apoptotic, neuroprotective and neurogenic properties that act on the nervous system as well as methods for making the same and their applications in the treatment and/or prevention or amelioration of neurodegenerative diseases related to neuronal apoptosis or neuronal injury, or conditions related to or resulting from apoptosis, including but not limited to Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis and amyotrophic lateral sclerosis (ALS), retinal degeneration and detachment, peripheral neuropathy caused by genetic abnormalities, diabetes, polio, herpes, AIDS and chemotherapy, brain trauma, or ischemia and stroke. The active compounds are represented by Formula (I): wherein R1, R2, R3, R4, R5, R6, R7, A, B, X, Y and Z are defined in the description of the invention. The present invention also includes compositions which comprise one or more of the compounds of Formula (I).
    Type: Application
    Filed: June 17, 2008
    Publication date: September 16, 2010
    Applicant: BIONATURE E. A. LTD.
    Inventors: Achilleas Gravanis, Theodora Calogeropoulou, Elias Castanas, Andreas Margioris, Ioannis Charalambopoulos, Nikolaos Avlonitis, Vassilios Minas, Vasileia-Ismini Alexaki, Christos Tsatsanis, Michael N. Alexis, Eumorphia Remboutsika, Varvara Vergou, Constantinos Neophytou